Abu Dhabi  ·  Pharmaceutical Holdings  ·  Est. 2022

Growing the
Future of Medicine

A2N Holdings is a purpose-led pharmaceutical investment group — rooted in Abu Dhabi, reaching across the world. Uniting visionary companies across drug discovery, injectable manufacturing, distribution, and precision healthcare.

Founded 2022  ·  Abu Dhabi, UAE

Scroll
4
Portfolio Companies
2022
Year Founded
12+
Focus Domains
UAE & Beyond
Global Reach

Who We Are

Rooted in Abu Dhabi,
Reaching the World

Founded in 2022 and proudly headquartered in Abu Dhabi, A2N Holdings was built on a powerful belief — that the UAE deserves to be a global force in pharmaceutical excellence. Abu Dhabi is not just our home; it is our launchpad.

From the heart of the UAE capital, we are building a portfolio of companies designed to make an impact far beyond our borders. Every investment we nurture in Abu Dhabi is engineered to serve patients across the region and around the world.

Like the tree that defines our identity, our roots run deep in Abu Dhabi soil — but our canopy stretches across continents.

"From Abu Dhabi, we are growing medicine for the world."
Abu Dhabi First
UAE-anchored strategy
Global Ambition
World-class standards
Innovation
Science at the frontier
Patient Impact
Health outcomes first

Our Leadership

The Founders Behind A2N Holdings

01
NS

Chairman & Managing Director

Neha Srivastava

Founder · Strategic Vision

"Healthcare is not a sector — it is a responsibility. Every decision we make at A2N is ultimately a decision about someone's health, someone's family. That is the standard we hold ourselves to."

— Neha Srivastava, Chairman & MD

02
AS

Managing Director

Ankit Srivastava

Co-Founder · Operations & Growth

"We build companies the right way — with discipline, with purpose, and with the patient always in mind. Sustainable growth in pharma is not about moving fast; it is about moving with precision."

— Ankit Srivastava, Managing Director

Portfolio Companies

Four Pillars of Healthcare Excellence

01

AI-Powered R&D · Medicine Discovery

OMS Pharma

Pioneering pharmaceutical R&D through artificial intelligence and cutting-edge discovery science. OMS Pharma leverages AI-driven molecular analysis and computational drug design to identify and develop breakthrough medicines.

02

Advanced Injectable Manufacturing

Medisal Pharma

The UAE's oldest and leading injectable pharmaceutical manufacturer with the largest production capacity in the country — delivering sterile medicines with world-class GMP standards and advanced aseptic fill-finish capabilities.

03

GCC & MENA Distribution

Dawaa Drug Store

A leading pharmaceutical distributor across the GCC and MENA region — connecting manufacturers with healthcare providers through a robust, technology-enabled network and ensuring critical medications reach patients.

04

Optics & Precision Healthcare

Lensea Pharma

Pioneering the convergence of precision optics and pharmaceutical science — delivering next-generation ophthalmic therapies, advanced contact lens technologies, and vision care solutions across the region.

Areas of Interest

Where We Invest Our Focus

From Abu Dhabi, we pursue transformational opportunities at the frontier of pharmaceutical science and global healthcare — building tomorrow's medicine ecosystem today.

01
AI-Powered Medicine Discovery
02
Next-Generation Medicines
03
Advanced Injectable Manufacturing
04
Biotech & Life Sciences Innovation
05
Pharma Deep Tech
06
Smart Pharma Manufacturing
07
Medicine Security & Resilient Supply Chains
08
Pharmaceutical Technology Transfer
09
Digital Pharma & Healthcare Intelligence
10
Precision Healthcare & Optics
11
Emerging Pharmaceutical Technologies
12
Global Pharma Partnerships

Partner With A2N

Ready to Build the
Future of Medicine?

info@a2n.ae